Nautilus Biotechnology Inc (NAUT) — 13F Filings Explorer (Q2 2026)

NAUT ranks #4740 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

NAUT is a disclosed holding of Marc Andreessen (Andreessen Horowitz (a16z)), one of the tracked superinvestors on AlphaSMO — it makes up 0.1% of that fund's own 13F portfolio.

94 institutions disclose a position in NAUT, but none treat it as a major bet — even Cercano Management LLC, its most concentrated holder, allocates just 1.3% of its own portfolio to it.

TD Waterhouse Canada Inc. has added to its NAUT position for two straight quarters, increasing it by $37.2K to reach $40.6K today.

FNY Investment Advisers, LLC has trimmed its NAUT position for two straight quarters, cutting it by $35.0K while still holding $19.0K.

NAUT is down 4.6% today, and institutions have been net sellers of $2.7M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

NAUT reported a net loss of $59.0M in its latest fiscal year.

• Not yet profitable — net loss of $59.0M in the latest fiscal year
• Net income improved year over year, from -$70.8M to -$59.0M
• Operating cash flow was negative, using $50.7M in cash
• Current ratio of 13.33x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.22x equity — within a conventional range